Ryu, M-H <br/><br/>
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Oct 2015 
 - 2097-101 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdv316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Follow-Up Studies<br/>Humans<br/>Lymphatic Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Oxonic Acid--administration & dosage<br/>Prognosis<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Tegafur--administration & dosage